Severity of necroinflamatory activity and fibrosis in SPARC<sup>+/+</sup> and SPARC<sup>−/−</sup> mice after 10 weeks of TAA treatment (n = 6–8) or in SPARC<sup>+/+</sup> and SPARC<sup>−/−</sup> BDL mice (n = 5–6).
收藏NIAID Data Ecosystem2026-03-07 收录
相关数据集
暂无相关数据集
